386 related articles for article (PubMed ID: 18619662)
21. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
[TBL] [Abstract][Full Text] [Related]
22. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate.
Shaw TJ; Vanderhyden BC
Gynecol Oncol; 2007 Apr; 105(1):122-31. PubMed ID: 17169414
[TBL] [Abstract][Full Text] [Related]
23. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells].
Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY
Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028
[TBL] [Abstract][Full Text] [Related]
24. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells.
Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY
Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674
[No Abstract] [Full Text] [Related]
25. [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line].
Ohsaki Y; Ishida S; Fujikane T; Akiba Y; Osanai S; Onodera S
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1339-43. PubMed ID: 2369137
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative effects of dehydrocostuslactone through cell cycle arrest and apoptosis in human ovarian cancer SK-OV-3 cells.
Choi EJ; Ahn WS
Int J Mol Med; 2009 Feb; 23(2):211-6. PubMed ID: 19148545
[TBL] [Abstract][Full Text] [Related]
27. [Enhanced effect of intraperitoneal administration of CDDP combined with caffeine against peritoneal metastasis].
Yamamoto Y; Amano T; Imada T; Akaike M; Noguchi Y; Aoyama N; Tsuburaya A; Rino Y; Takehana T; Hasuo K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1825-31. PubMed ID: 1877825
[TBL] [Abstract][Full Text] [Related]
28. Caffeine overcomes genistein-induced G2/M cell cycle arrest in breast cancer cells.
Li Z; Liu W; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Nutr Cancer; 2008; 60(3):382-8. PubMed ID: 18444173
[TBL] [Abstract][Full Text] [Related]
29. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
[TBL] [Abstract][Full Text] [Related]
30. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
Takeda A; Tsuchiya H; Tajino T; Kikuchi S
Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
32. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
Yan XD; Li M; Yuan Y; Mao N; Pan LY
Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
[TBL] [Abstract][Full Text] [Related]
33. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
34. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.
Bodo J; Chovancova J; Hunakova L; Sedlak J
Neoplasma; 2005; 52(6):510-6. PubMed ID: 16284698
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro.
Papazisis KT; Kalemi TG; Zambouli D; Geromichalos GD; Lambropoulos AF; Kotsis A; Boutis LL; Kortsaris AH
Cancer Lett; 2006 Feb; 233(2):255-64. PubMed ID: 15893418
[TBL] [Abstract][Full Text] [Related]
36. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
[TBL] [Abstract][Full Text] [Related]
37. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
Lee S; Yoon S; Kim DH
Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
[TBL] [Abstract][Full Text] [Related]
38. Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II).
Husain A; Rosales N; Schwartz GK; Spriggs DR
Gynecol Oncol; 1998 Jul; 70(1):17-22. PubMed ID: 9698467
[TBL] [Abstract][Full Text] [Related]
39. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.
Chang HL; Su JH; Yeh YT; Lee YC; Chen HM; Wu YC; Yuan SS
Cancer Lett; 2008 Aug; 267(1):85-95. PubMed ID: 18430509
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
